Abstract
Abnormal combustions occurred since the invention of internal combustion engines. Knock was intensively studied by researchers and engineers since this date. First patents were taken out on fuel quality (defined by octane index nowadays). After patents on sensors itself, engine settings were piloted to eliminate knock conditions in 1979-1980. Many companies followed this pathway. Latest patents on knock are reviewed. A highlight on a preventive protection (open loop control) is proposed for stationary engines fuelled natural gas, see Le Corre et al. [1]: this patent is a new concept in rupture with curative protection (closed loop control). Preventive protection is based on a gas quality sensor.
Keywords: Knock protection, abnormal combustions, internal combustion engine
Recent Patents on Engineering
Title: Abnormal Combustions in Internal Combustion Engines: Review on the Latest Patents Eliminating Knock Conditions
Volume: 4 Issue: 2
Author(s): O. Le Corre
Affiliation:
Keywords: Knock protection, abnormal combustions, internal combustion engine
Abstract: Abnormal combustions occurred since the invention of internal combustion engines. Knock was intensively studied by researchers and engineers since this date. First patents were taken out on fuel quality (defined by octane index nowadays). After patents on sensors itself, engine settings were piloted to eliminate knock conditions in 1979-1980. Many companies followed this pathway. Latest patents on knock are reviewed. A highlight on a preventive protection (open loop control) is proposed for stationary engines fuelled natural gas, see Le Corre et al. [1]: this patent is a new concept in rupture with curative protection (closed loop control). Preventive protection is based on a gas quality sensor.
Export Options
About this article
Cite this article as:
Le Corre O., Abnormal Combustions in Internal Combustion Engines: Review on the Latest Patents Eliminating Knock Conditions, Recent Patents on Engineering 2010; 4 (2) . https://dx.doi.org/10.2174/187221210791233407
DOI https://dx.doi.org/10.2174/187221210791233407 |
Print ISSN 1872-2121 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4047 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Digitalis-like Compounds: the Discovery of the O-aminoalkyloxime Group as a Very Powerful Substitute for the Unsaturated γ-Butyrolactone Moiety
Current Medicinal Chemistry Nuclear Membranes GPCRs: Implication in Cardiovascular Health and Diseases
Current Vascular Pharmacology EDITORIAL (Hot Topic: Renal Sympathetic Denervation and Cardiovascular Disease: Past, Present and Future)
Current Clinical Pharmacology Preface [Hot Topic: Molecular and Cellular Mechanisms of Ischemic Cell Death in the Brain (Executive Editor: Rita Sattler)]
Current Molecular Medicine Combination of Captopril with Gliclazide Decreases Vascular and Renal Complications and Improves Glycemic Control in Rats with Streptozotocin- Induced Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Current Diabetes Reviews Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer's Disease
Current Alzheimer Research Effects of Pulmonary Blood Flow on Respiratory Mechanics: Measurements by the End-Inflation Occlusion Method in Healthy Rats After Acute Blood Volume Expansion
Current Respiratory Medicine Reviews Treatment of Hypertension Induced Albuminuria
Current Pharmaceutical Design Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design PPAR-γ: Therapeutic Prospects in Parkinson's Disease
Current Drug Targets “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy Pharmacokinetics/Pharmacodynamics Model-Supported Early Drug Development
Current Pharmaceutical Biotechnology Good Practices in Forensic Toxicology
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Drug Targets Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design Telomeres and their Role in Aging and Longevity
Current Vascular Pharmacology In Vivo Imaging of the Diseased Nervous System: An Update
Current Pharmaceutical Design New Approaches to Raising the HDL Cholesterol Level
Mini-Reviews in Medicinal Chemistry Chondroitin Sulfate, a Major Niche Substance of Neural Stem Cells, and Cell Transplantation Therapy of Neurodegeneration Combined with Niche Modification
Current Stem Cell Research & Therapy